In the realm of molecular biology, we often focus on cellular mechanisms, gene expression, and innovations in targeted therapies. But when these scientific advancements intersect with real-life stories, they transcend abstraction and become vessels of hope and hardship for ...Learn More

In the ever-evolving landscape of oncology, few stories capture the intersection of scientific innovation and personal resilience quite like those surrounding acute lymphoblastic leukemia (ALL). As we navigate 2025, a year marked by heightened awareness of social isolation among ...Learn More

As observers in the global pharmaceutical landscape, we at DengYueMed have witnessed the rapid evolution of China's oncology sector. With a focus on facilitating the flow of innovative therapies across borders, we see these developments not just as scientific milestones but as ...Learn More

At DengYueMed, we are witnessing and actively driving a profound transformation in the global oncology treatment landscape—from drug shortages and originator monopolies to a more diversified supply chain and multi-market collaboration. Our latest cross-border partnerships ...Learn More

Author: DengYueMed Publication Date: December 11, 2025 In the increasingly competitive global pharmaceutical industry, China's innovative drug companies have accelerated their internationalization efforts to unprecedented heights in 2025. According to the latest industry data, the ...Learn More